FluoroPharma Medical, Inc. (OTCBB:FPMI) announced a private placement of 10% promissory note for gross proceeds of $500,000 on June 21, 2013. The promissory note carries a coupon of 10% per annum. The outstanding principal amount of the notes held by each purchaser issued plus 10% of the principal amount shall be exchanged by the purchaser for the applicable dollar amount of securities to be sold by the company in a subsequent financing transaction that occurs prior to the maturity date of the notes. The company will issue securities pursuant to exemption provided under Regulation D. LifeTech Capital and Marc Ross of Sichenzia Ross Friedman Ference LLP will act as placement agent and legal advisor respectively to the company.

On the same date, the company announced that it has received $150,000 from an investor. The company issued a 10% promissory note in the principal amount of $150,000 and would mature on December 21, 2013.